Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta

Thromb Res. 2008;122(3):376-82. doi: 10.1016/j.thromres.2007.12.016. Epub 2008 Mar 14.

Abstract

Introduction: Few studies have been carried out to investigate whether distinct areas of full term placenta express different amounts of markers involved in the placental haemostasis and angiogenesis. A possible relationship between the expression of genes involved in the haemostasis and angiogenesis of human placenta has not been investigated.

Materials and methods: Twenty-eight fresh human placentas (35-41 weeks of gestation) from uneventful pregnancies were dissected with two different methods. Quantitative mRNA expression of the tissue factor (TF), TF pathway inhibitor (TFPI), TFPI-2, plasminogen activator inhibitor (PAI-2), annexin V (Anx V), vascular endothelial growth factor (VEGF), and thrombomodulin (TM) genes was evaluated by quantitative real time PCR system. Histology of each sample was graded.

Results: Gene expression of all the considered markers was not significantly different in each area, using both the different methods of dissection. A significant correlation (p<0.05) was found between the expression of TF and TFPI-2. TF and TFPI-2 were significantly (p<0.05) associated with VEGF, whereas a stronger association (p<0.01) was found between TFPI and TFPI-2. TFPI and TFPI-2 were strongly associated with PAI-2 expression (p<0.01).

Conclusions: In placentas with central cord insertion, gene expression is not dependent on the method of sampling site. A significant relationship between haemostasis and angiogenesis in at term placentas was shown.

MeSH terms

  • Annexin A5 / genetics
  • Annexin A5 / metabolism
  • Female
  • Gene Expression / physiology
  • Glycoproteins / genetics
  • Glycoproteins / metabolism
  • Hemostasis / physiology*
  • Humans
  • Lipoproteins / genetics
  • Lipoproteins / metabolism
  • Neovascularization, Physiologic / physiology*
  • Placenta / blood supply*
  • Placenta / cytology
  • Placenta / physiology*
  • Plasminogen Activator Inhibitor 2 / genetics
  • Plasminogen Activator Inhibitor 2 / metabolism
  • Pregnancy
  • RNA, Messenger / metabolism
  • Thrombomodulin / genetics
  • Thrombomodulin / metabolism
  • Thromboplastin / genetics
  • Thromboplastin / metabolism
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Annexin A5
  • Glycoproteins
  • Lipoproteins
  • Plasminogen Activator Inhibitor 2
  • RNA, Messenger
  • Thrombomodulin
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • lipoprotein-associated coagulation inhibitor
  • tissue-factor-pathway inhibitor 2
  • Thromboplastin